4
Changes in Ownership
Immix Biopharma, Inc. Filed Acc 0001493152-22-019497
Options or other derivatives
- CFO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S CFO | 2022-07-14 | Grant or award · Stock Options | +250,000 | 716,500 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…